Boston Scientific Corp. vs. SkinHealth Systems Inc. Class A Common Stock
BSX
Boston Scientific Corp.
$49.86 +1.73%
VS SKINSkinHealth Systems Inc. Class A Common Stock
$0.65 -4.40%
Boston Scientific Corp. (BSX) comes out ahead, leading on 2 of 2 compared factors.
Size & Scale
| BSX | SKIN | |
|---|---|---|
| Market Cap | $71.03 billion | $84.60 million |
| Revenue (TTM) | $21.00 billion | — |
| Net Income (TTM) | $3.67 billion | — |
BSX leads on 1 of 1 size & scale factors.
Valuation
| BSX | SKIN | |
|---|---|---|
| P/E Ratio | 20.19 | — |
| Price / Book | 2.82 | — |
| Price / Sales | 3.38 | — |
BSX and SKIN split the valuation factors evenly.
Profitability
| BSX | SKIN | |
|---|---|---|
| Net Margin | 17.47% | — |
| Return on Equity | 14.57% | — |
BSX and SKIN split the profitability factors evenly.
Risk & Sentiment
| BSX | SKIN | |
|---|---|---|
| Short Interest | 0.72% | 1.43% |
BSX leads on 1 of 1 risk & sentiment factors.
Dig deeper: BSX overview, BSX financials, SKIN overview, SKIN financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.